Neurotrophic Factors for the Investigation and Treatment of Movement Disorders
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
225-238
Author(s):
J. Garcia de Yebenes and M. P. Sanchez
Development of Neurotrophic Molecules for Treatment of Neurode-generation
Journal:
Current Protein & Peptide Science
Volume:
2
Page:
261-276
Author(s):
Zhe-yu Chen, Li Cao, Li-mei Wang, Chao Guo, Jun-Li Ye, Yan-Feng Chai and Zhi-Yong Yan
Chemistry and Biochemistry of Oxidative Stress in Neurodegenerative Disease
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
721-738
Author(s):
Lawrence M. Sayre, Mark A. Smith and George Perry
The Genetics of Frontotemporal Dementia and Related Disorders
Journal:
Current Genomics
Volume:
1
Page:
339-352
Author(s):
M. J. Sobrido, M. Wiedau-Pazos and D. H. Geschwind
Chemical and Pharmacological Aspects of Heteroaryl-Nitrones
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1255-1267
Author(s):
Solo Goldstein and Pierre Lestage
Conantokins Inhibitors of Ion Flow through the N-Methyl-D-Aspartate Receptor Channels
Journal:
Current Drug Targets
Volume:
1
Page:
219-235
Author(s):
Francis J. Castellin and Mary Porok
PET Studies of Brain Monoamine Transporters
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1611-1623
Author(s):
Aki Laakso and Jarmo Hietala
Withdrawn: Mesenchymal Stem Cell-derived Exosomes for Treatment of Ischemic Stroke
Journal:
Current Stem Cell Research & Therapy
Volume:
16
Page:
1-1
Author(s):
Rucheng Liu , Yi Zhang, Yundi Zhang*, Maryam Farzaneh* and Seyed Esmaeil Khoshnam
Withdrawn Notice: Nanocarriers’- An Efficient Drug Delivery System for Neurodegenerative Disorders Including Alzheimer’s, Parkinson’s, Huntington, Amyotrophic Lateral Sclerosis and Associated Risk of Nanocarriers, Future Perspectives - A Review
Journal:
Current Drug Targets
Volume:
23
Page:
1-1
Author(s):
Sumel Ashique*